Advertisement Florida Biologix aseptic fill-finish facility meets European GMP requirements - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Florida Biologix aseptic fill-finish facility meets European GMP requirements

Florida Biologix has said that its aseptic fill and finish facility for biopharmaceutical drug products meets European GMP requirements.

The enhancements provide an outstanding and cost competitive services for filling Phase I/II drug products into vials or other containers, the company said.

Florida Biologix provides either manual or automated filling services up to 4,000 vials per lot.

Florida Biologix has invested in GMP facility improvements, as well as outfitted additional classified support space and is adding new warehouse areas to better serve clients’ needs.

Florida Biologix associate director Joyce Francis said that the improvements support their multi-year production contracts.